MB-dNPM1-TCR.1

· Miltenyi Biomedicine GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MB-dNPM1-TCR.1, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: MB-dNPM1-TCR.1 in Relapsed/Refractory AML [Phase 1, Phase 2]